Cargando…
Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage
Early diagnosis of colorectal cancer (CRC) is clinically critical but technically challenging, especially in a minimal-invasive way. Emerging evidence suggests that exosome-encapsulated microRNAs (miRNAs) is a kind of promising cancer biomarker. Here we investigated the predictive potential of exoso...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775270/ https://www.ncbi.nlm.nih.gov/pubmed/31588188 http://dx.doi.org/10.7150/ijms.34540 |
_version_ | 1783456206795309056 |
---|---|
author | Min, Li Chen, Lei Liu, Si Yu, Yang Guo, Qingdong Li, Peng Zhu, Shengtao |
author_facet | Min, Li Chen, Lei Liu, Si Yu, Yang Guo, Qingdong Li, Peng Zhu, Shengtao |
author_sort | Min, Li |
collection | PubMed |
description | Early diagnosis of colorectal cancer (CRC) is clinically critical but technically challenging, especially in a minimal-invasive way. Emerging evidence suggests that exosome-encapsulated microRNAs (miRNAs) is a kind of promising cancer biomarker. Here we investigated the predictive potential of exosomal miR-92b in plasma samples obtained from 114 participants [40 CRC, 22 colorectal adenomas (CA), 52 non-neoplasm controls (NC)] by RT-qPCR. We found that exosomal miR-92b level was significantly down-regulated in CRC patients compared with CA and NC patients, especially in CRC at stage II, regardless of lymph node metastasis and invasive depth. The AUC in distinguishing CRC, CA and NC from each other ranged from 0.631 to 0.793, while a higher AUC of 0.830 was achieved in differentiating CRC at clinical stage II/III from NC individuals. Additionally, a logistic model integrating miR-92b with age showed a significantly improved accuracy in distinguishing CRC patients from NC (AUC increased from 0.793 to 0.867). Taken together, our findings indicated that decreased expression of exosome-derived miR-92b in plasma is a promising biomarker for early detection of CRC. |
format | Online Article Text |
id | pubmed-6775270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-67752702019-10-04 Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage Min, Li Chen, Lei Liu, Si Yu, Yang Guo, Qingdong Li, Peng Zhu, Shengtao Int J Med Sci Research Paper Early diagnosis of colorectal cancer (CRC) is clinically critical but technically challenging, especially in a minimal-invasive way. Emerging evidence suggests that exosome-encapsulated microRNAs (miRNAs) is a kind of promising cancer biomarker. Here we investigated the predictive potential of exosomal miR-92b in plasma samples obtained from 114 participants [40 CRC, 22 colorectal adenomas (CA), 52 non-neoplasm controls (NC)] by RT-qPCR. We found that exosomal miR-92b level was significantly down-regulated in CRC patients compared with CA and NC patients, especially in CRC at stage II, regardless of lymph node metastasis and invasive depth. The AUC in distinguishing CRC, CA and NC from each other ranged from 0.631 to 0.793, while a higher AUC of 0.830 was achieved in differentiating CRC at clinical stage II/III from NC individuals. Additionally, a logistic model integrating miR-92b with age showed a significantly improved accuracy in distinguishing CRC patients from NC (AUC increased from 0.793 to 0.867). Taken together, our findings indicated that decreased expression of exosome-derived miR-92b in plasma is a promising biomarker for early detection of CRC. Ivyspring International Publisher 2019-08-14 /pmc/articles/PMC6775270/ /pubmed/31588188 http://dx.doi.org/10.7150/ijms.34540 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Min, Li Chen, Lei Liu, Si Yu, Yang Guo, Qingdong Li, Peng Zhu, Shengtao Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage |
title | Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage |
title_full | Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage |
title_fullStr | Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage |
title_full_unstemmed | Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage |
title_short | Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage |
title_sort | loss of circulating exosomal mir-92b is a novel biomarker of colorectal cancer at early stage |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775270/ https://www.ncbi.nlm.nih.gov/pubmed/31588188 http://dx.doi.org/10.7150/ijms.34540 |
work_keys_str_mv | AT minli lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage AT chenlei lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage AT liusi lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage AT yuyang lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage AT guoqingdong lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage AT lipeng lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage AT zhushengtao lossofcirculatingexosomalmir92bisanovelbiomarkerofcolorectalcanceratearlystage |